Company Profile
AIM ImmunoTech Stock Price, News & Analysis
- Ticker:
- AIM
- Exchange:
- AMEX
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
0.27 USD (-6.01%)
Close
Last updated: July 13, 2026 at 00:00
7.85M USD
Market cap
Why the stock is moving
AIM is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
AIM ImmunoTech is an immunology-oriented biopharmaceutical company focused on inflammatory and immune-mediated disease programs, where each new data point can reshape expectations for the pipeline and the next catalyst window.
Geographic Base and Sector Classification
Headquartered in the United States and listed on 美国证券交易所, AIM ImmunoTech is followed within the immunology universe for its exposure to chronic-disease treatment demand and catalyst-driven clinical updates.
Business Model Characteristics
AIM ImmunoTech is a pipeline-led immunology story, so the market tends to track readouts, regulatory milestones, and how the company expands from one immune program to the next.
Position Within the Biotechnology Landscape
Compared with more mature peers, AIM ImmunoTech sits close to the development side of the biotech landscape, where immunology data can change sentiment quickly.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 03
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of AIM ImmunoTech (AIM)?
AIM ImmunoTech (AIM) most recently closed at 0.27 USD, a -6.01% move versus the previous session.
What is the market cap of AIM ImmunoTech (AIM)?
AIM ImmunoTech currently has a market capitalization of 7.85M USD on BioPharmSignal.
What does AIM ImmunoTech do?
AIM ImmunoTech is an immunology-oriented biopharmaceutical company focused on inflammatory and immune-mediated disease programs, where each new data point can reshape expectations for the pipeline and the next catalyst window.
On which exchange is AIM stock listed?
AIM ImmunoTech (AIM) is associated with AMEX, United States, Biotechnology.
What is ImmunoTech?
AIM ImmunoTech is an immunology-oriented biopharmaceutical company focused on inflammatory and immune-mediated disease programs, where each new data point can reshape expectations for the pipeline and the next catalyst window.
Which conditions is AIM ImmunoTech targeting with ImmunoTech?
AIM ImmunoTech is associated with immunology based on its company overview and current catalyst commentary.